Recurrent Ovarian Low Grade Serous Adenocarcinoma

specific

The reemergence of ovarian low-grade serous adenocarcinoma after a period of remission.

53

Centers

43

Active Trials

Cancer Funding

Top Centers for Recurrent Ovarian Low Grade Serous Adenocarcinoma(53)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
172.2
2
NCI Comprehensive
High-Volume Research Center
72.2
3
NCI Comprehensive
High-Volume Research Center
72.2
4
NCI Comprehensive
Active Research Program
55.2
5
NCI Comprehensive
Active Research Program
55.2
6
NCI Comprehensive
Active Research Program
55.2
7
NCI Comprehensive
Active Research Program
55.2
8
NCI Comprehensive
Active Research Program
55.2
9
NCI Comprehensive
Active Research Program
55.2
10
NCI Comprehensive
Active Research Program
55.2
11
NCI Comprehensive
Active Research Program
55.2
12
NCI Comprehensive
Active Research Program
55.2
13
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
55.2
14
NCI Comprehensive
Active Research Program
55.2
15
NCI Comprehensive
Active Research Program
55.2
16
NCI Comprehensive
Active Research Program
55.2
17
NCI Comprehensive
Active Research Program
55.2
18
NCI Comprehensive
Active Research Program
55.2
19
NCI Comprehensive
Active Research Program
55.2
20
NCI Clinical
Active Research Program
55.2
21
NCI Comprehensive
Active Research Program
55.2
22
Active Research Program
55.2
23
Active Research Program
55.2
24
NCI Comprehensive
Active Research Program
55.2
25
NCI Clinical
Active Research Program
55.2
26
NCI Comprehensive
Active Research Program
55.2
27
Active Research Program
55.2
28
NCI Clinical
Active Research Program
55.2
29
NCI Comprehensive
Active Research Program
55.2
30
Active Research Program
55.2
31
Active Research Program
55.2
3255.2
33
Active Research Program
55.2
34
Active Research Program
55.2
35
Active Research Program
55.2
36
Active Research Program
55.2
3755.2
38
Active Research Program
55.2
39
Active Research Program
55.2
40
Active Research Program
55.2
41
NCI Comprehensive
34.0
4234.0
4334.0
44
NCI Comprehensive
34.0
45
NCI Comprehensive
34.0
46
NCI Comprehensive
34.0
47
NCI Comprehensive
34.0
4834.0
4934.0
50
NCI Comprehensive
34.0
51
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
34.0
5234.0
5334.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →